» Articles » PMID: 32974152

Importance of Crosstalk Between Chronic Lymphocytic Leukemia Cells and the Stromal Microenvironment: Direct Contact, Soluble Factors, and Extracellular Vesicles

Overview
Journal Front Oncol
Specialty Oncology
Date 2020 Sep 25
PMID 32974152
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic lymphocytic leukemia (CLL) is caused by the accumulation of malignant B cells due to a defect in apoptosis and the presence of small population of proliferating cells principally in the lymph nodes. The abnormal survival of CLL B cells is explained by a plethora of supportive stimuli produced by the surrounding cells of the microenvironment, including follicular dendritic cells (FDCs), and mesenchymal stromal cells (MSCs). This crosstalk between malignant cells and normal cells can take place directly by cell-to-cell contact (assisted by adhesion molecules such as VLA-4 or CD100), indirectly by soluble factors (chemokines such as CXCL12, CXCL13, or CCL2) interacting with their receptors or by the exchange of material (protein, microRNAs or long non-coding RNAs) via extracellular vesicles. These different communication methods lead to different activation pathways (including BCR and NFκB pathways), gene expression modifications (chemokines, antiapoptotic protein increase, prognostic biomarkers), chemotaxis, homing in lymphoid tissues and survival of leukemic cells. In addition, these interactions are bidirectional, and CLL cells can manipulate the normal surrounding stromal cells in different ways to establish a supportive microenvironment. Here, we review this complex crosstalk between CLL cells and stromal cells, focusing on the different types of interactions, activated pathways, treatment strategies to disrupt this bidirectional communication, and the prognostic impact of these induced modifications.

Citing Articles

Tumor microenvironment as a novel therapeutic target for lymphoid leukemias.

Mousavi S, Nouri S, Sadeghipour A, Atashi A Ann Hematol. 2025; .

PMID: 39994019 DOI: 10.1007/s00277-025-06237-w.


Extracellular vesicles from chronic lymphocytic leukemia cells promote leukemia aggressiveness by inducing the differentiation of monocytes into nurse-like cells via an RNA-dependent mechanism.

Dubois N, Van Morckhoven D, Tilleman L, Van Nieuwerburgh F, Bron D, Lagneaux L Hemasphere. 2025; 9(1):e70068.

PMID: 39822586 PMC: 11735956. DOI: 10.1002/hem3.70068.


Tumor Cell Survival Factors and Angiogenesis in Chronic Lymphocytic Leukemia: How Hot Is the Link?.

Ayoub M, Susin S, Bauvois B Cancers (Basel). 2025; 17(1.

PMID: 39796700 PMC: 11719013. DOI: 10.3390/cancers17010072.


Effects, methods and limits of the cryopreservation on mesenchymal stem cells.

Wang J, Li R Stem Cell Res Ther. 2024; 15(1):337.

PMID: 39343920 PMC: 11441116. DOI: 10.1186/s13287-024-03954-3.


Increased Frequency of Circulating Activated FOXP3 Regulatory T Cell Subset in Patients with Chronic Lymphocytic Leukemia Is Associated with the Estimate of the Size of the Tumor Mass, STAT5 Signaling and Disease Course during Follow-Up of Patients....

Roskar Z, Dreisinger M, Homsak E, Avcin T, Bevc S, Goropevsek A Cancers (Basel). 2024; 16(18).

PMID: 39335199 PMC: 11430700. DOI: 10.3390/cancers16183228.


References
1.
Ganghammer S, Hutterer E, Hinterseer E, Brachtl G, Asslaber D, Krenn P . CXCL12-induced VLA-4 activation is impaired in trisomy 12 chronic lymphocytic leukemia cells: a role for CCL21. Oncotarget. 2015; 6(14):12048-60. PMC: 4494922. DOI: 10.18632/oncotarget.3660. View

2.
Sivina M, Hartmann E, Kipps T, Rassenti L, Krupnik D, Lerner S . CCL3 (MIP-1α) plasma levels and the risk for disease progression in chronic lymphocytic leukemia. Blood. 2010; 117(5):1662-9. PMC: 3318778. DOI: 10.1182/blood-2010-09-307249. View

3.
OHayre M, Salanga C, Kipps T, Messmer D, Dorrestein P, Handel T . Elucidating the CXCL12/CXCR4 signaling network in chronic lymphocytic leukemia through phosphoproteomics analysis. PLoS One. 2010; 5(7):e11716. PMC: 2908618. DOI: 10.1371/journal.pone.0011716. View

4.
FRIEDENSTEIN A, PETRAKOVA K, Kurolesova A, Frolova G . Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation. 1968; 6(2):230-47. View

5.
Minden M, Ubelhart R, Schneider D, Wossning T, Bach M, Buchner M . Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling. Nature. 2012; 489(7415):309-12. DOI: 10.1038/nature11309. View